A significant discovery in cancer study is emerging with the use of mini-antibodies to restore dysfunctional p53. This essential tumor inhibitor protein is frequently disabled in many types of cancer, leading https://social-lyft.com/story12078424/mini-antibodies-reactivate-tumor-suppressor-p53-a-promising-pathway-for-malignant-management